Below, we provide an overview of the endocannabinoid system, highlight overlapping pathways with CDKL5, provide an overview of CDD models, and speculate on the utility of CBD treatment in CDD and other genetic epilepsies. This evidence concerns the gene CDKL5 and craniodiaphyseal dysplasia.